BioCentury
ARTICLE | Clinical News

Anavex preclinical data

December 3, 2007 8:00 AM UTC

In a mouse model of AD, ANAVEX 1-41 protected against amyloid beta peptide-induced memory deficits. The tetrahydrofuranic compound also blocked the expression of caspase-3, which AVXL said it involve...